Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry Norton

Showing results (21-30 of 293) with videos related to

Pageof 30
Sort By:
Journal of the National Cancer Institute|July 18, 2013
Epoetin alfa: to give or not to giveChau Dang, Clifford Hudis, Larry Norton
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Dose-dense chemotherapy with trastuzumab is an appropriate optionChau Dang, Larry Norton, Clifford Hudis
Journal of Mammary Gland Biology and Neoplasia|September 27, 2012
Translating mathematical modeling of tumor growth patterns into novel therapeutic approaches for breast cancerElizabeth Comen, Patrick G Morris, Larry Norton
Nature Reviews. Clinical Oncology|January 28, 2015
Current management of lesions associated with an increased risk of breast cancerMonica Morrow, Stuart J Schnitt, Larry Norton
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Breast cancer tumor size, nodal status, and prognosis: biology trumps anatomyElizabeth A Comen, Larry Norton, Joan Massagué
Clinical Breast Cancer|September 26, 2016
A Rare Case of S310F Somatic ERBB2 Mutation in a HER2-Nonamplified Breast CancerSakshi Jasra, Mateusz Opyrchal, Larry Norton, et al.
The Oncologist|November 18, 2006
Nasal septum perforation in a bevacizumab-treated patient with metastatic breast cancerTiffany A Traina, Larry Norton, Karen Drucker, et al.
The Journal of Biological Chemistry|March 20, 2002
Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3Kotha Subbaramaiah, Larry Norton, William Gerald, et al.
Scientific Reports|December 1, 2020
Fractional SIR epidemiological modelsAmirhossein Taghvaei, Tryphon T Georgiou, Larry Norton, et al.
Trends in Pharmacological Sciences|November 22, 2022
Targeting stressor-induced dysfunctions in protein-protein interaction networks via epichaperomesStephen D Ginsberg, Sahil Sharma, Larry Norton, et al.
Pageof 30

Showing results (21-30 of 293) with videos related to

Sort By:
Pageof 30
Journal of the National Cancer Institute|July 18, 2013
Epoetin alfa: to give or not to giveChau Dang, Clifford Hudis, Larry Norton
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Dose-dense chemotherapy with trastuzumab is an appropriate optionChau Dang, Larry Norton, Clifford Hudis
Journal of Mammary Gland Biology and Neoplasia|September 27, 2012
Translating mathematical modeling of tumor growth patterns into novel therapeutic approaches for breast cancerElizabeth Comen, Patrick G Morris, Larry Norton
Nature Reviews. Clinical Oncology|January 28, 2015
Current management of lesions associated with an increased risk of breast cancerMonica Morrow, Stuart J Schnitt, Larry Norton
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Breast cancer tumor size, nodal status, and prognosis: biology trumps anatomyElizabeth A Comen, Larry Norton, Joan Massagué
Clinical Breast Cancer|September 26, 2016
A Rare Case of S310F Somatic ERBB2 Mutation in a HER2-Nonamplified Breast CancerSakshi Jasra, Mateusz Opyrchal, Larry Norton, et al.
The Oncologist|November 18, 2006
Nasal septum perforation in a bevacizumab-treated patient with metastatic breast cancerTiffany A Traina, Larry Norton, Karen Drucker, et al.
The Journal of Biological Chemistry|March 20, 2002
Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3Kotha Subbaramaiah, Larry Norton, William Gerald, et al.
Scientific Reports|December 1, 2020
Fractional SIR epidemiological modelsAmirhossein Taghvaei, Tryphon T Georgiou, Larry Norton, et al.
Trends in Pharmacological Sciences|November 22, 2022
Targeting stressor-induced dysfunctions in protein-protein interaction networks via epichaperomesStephen D Ginsberg, Sahil Sharma, Larry Norton, et al.
Pageof 30